Total Payments
$662.24
2023 Payments
$159.04
Companies
7
Transactions
13
Medicare Patients
8,023
Medicare Billing
$894,046
Payment Breakdown by Category
Food & Beverage$465.44 (70.3%)
Other$150.00 (22.7%)
Education$46.80 (7.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $465.44 | 11 | 70.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $150.00 | 1 | 22.7% |
| Education | $46.80 | 1 | 7.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alcon Vision LLC | $223.80 | 6 | $0 (2023) |
| Shire North American Group Inc | $150.00 | 1 | $0 (2018) |
| Allergan Inc. | $114.20 | 2 | $0 (2018) |
| Ivantis, Inc | $75.77 | 1 | $0 (2020) |
| Genentech USA, Inc. | $46.80 | 1 | $0 (2022) |
| Iridex Corporation | $27.27 | 1 | $0 (2022) |
| Horizon Therapeutics plc | $24.40 | 1 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $159.04 | 2 | Alcon Vision LLC ($159.04) |
| 2022 | $163.23 | 7 | Alcon Vision LLC ($64.76) |
| 2020 | $75.77 | 1 | Ivantis, Inc ($75.77) |
| 2018 | $244.13 | 2 | Shire North American Group Inc ($150.00) |
| 2017 | $20.07 | 1 | Allergan Inc. ($20.07) |
All Payment Transactions
13 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/17/2023 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $83.98 | General |
| Category: Ophthalmology | ||||||
| 08/17/2023 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $75.06 | General |
| Category: Ophthalmology | ||||||
| 11/15/2022 | Genentech USA, Inc. | VABYSMO (Drug) | Education | In-kind items and services | $46.80 | General |
| Category: Immunology and Ophthalmology | ||||||
| 09/10/2022 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Ophthalmology | ||||||
| 09/10/2022 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $17.07 | General |
| Category: Ophthalmology | ||||||
| 09/10/2022 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Ophthalmology | ||||||
| 09/10/2022 | Alcon Vision LLC | Centurion (Device) | Food and Beverage | In-kind items and services | $15.31 | General |
| Category: Ophthalmology | ||||||
| 06/13/2022 | Horizon Therapeutics plc | TEPEZZA (Drug) | Food and Beverage | In-kind items and services | $24.40 | General |
| Category: TEPEZZA | ||||||
| 05/25/2022 | Iridex Corporation | — | Food and Beverage | Cash or cash equivalent | $27.27 | General |
| 09/15/2020 | Ivantis, Inc | Hydrus (Device) | Food and Beverage | In-kind items and services | $75.77 | General |
| Category: Ophthalmic Surgery | ||||||
| 07/18/2018 | Allergan Inc. | LUMIGAN (Drug), COMBIGAN | Food and Beverage | In-kind items and services | $94.13 | General |
| Category: OPHTHALMOLOGY | ||||||
| 03/14/2018 | Shire North American Group Inc | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $150.00 | General |
| 04/04/2017 | Allergan Inc. | RESTASIS (Drug) | Food and Beverage | In-kind items and services | $20.07 | General |
| Category: DRY EYE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 22 | 1,579 | 2,162 | $288,593 | $146,378 |
| 2022 | 22 | 2,039 | 3,105 | $351,805 | $212,903 |
| 2021 | 21 | 2,383 | 3,684 | $399,526 | $252,317 |
| 2020 | 22 | 2,022 | 3,252 | $450,218 | $282,449 |
Total Patients
8,023
Total Services
12,203
Medicare Billing
$894,046
Procedure Codes
87
All Medicare Procedures & Services
87 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0178 | Injection, aflibercept, 1 mg | Office | 2023 | 12 | 60 | $71,715 | $41,637 | 58.1% |
| 92014 | Established patient complete exam of visual system | Office | 2023 | 234 | 252 | $45,696 | $22,915 | 50.1% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 150 | 217 | $29,397 | $15,282 | 52.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 186 | 286 | $28,028 | $14,934 | 53.3% |
| 92134 | Imaging of retina | Office | 2023 | 361 | 507 | $31,354 | $13,873 | 44.2% |
| 67028 | Injection of drug into eye | Office | 2023 | 20 | 66 | $9,743 | $5,661 | 58.1% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 17 | 69 | $12,189 | $5,063 | 41.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 40 | 44 | $8,204 | $4,464 | 54.4% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Office | 2023 | 14 | 16 | $6,738 | $4,279 | 63.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 116 | 159 | $9,540 | $4,110 | 43.1% |
| 92250 | Photography of the retina | Office | 2023 | 140 | 155 | $11,120 | $3,557 | 32.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 23 | 23 | $6,164 | $2,878 | 46.7% |
| J9035 | Injection, bevacizumab, 10 mg | Office | 2023 | 16 | 37 | $3,442 | $2,039 | 59.2% |
| 92133 | Imaging of optic nerve | Office | 2023 | 47 | 53 | $3,149 | $1,470 | 46.7% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 18 | 20 | $2,020 | $1,040 | 51.5% |
| 92025 | Ct scan of cornea | Office | 2023 | 69 | 73 | $3,551 | $1,005 | 28.3% |
| 92082 | Exam of visual field with intermediate testing | Office | 2023 | 34 | 35 | $2,275 | $913.10 | 40.1% |
| 99202 | New patient office or other outpatient visit, 15-29 minutes | Office | 2023 | 13 | 13 | $1,209 | $413.91 | 34.2% |
| 92285 | Photography of content of eyes | Office | 2023 | 29 | 32 | $1,120 | $349.29 | 31.2% |
| 65205 | Removal of foreign body from external eye (conjunctiva) | Office | 2023 | 15 | 17 | $1,050 | $239.44 | 22.8% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 11 | 11 | $488.00 | $155.80 | 31.9% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 14 | 17 | $401.00 | $97.14 | 24.2% |
| J0178 | Injection, aflibercept, 1 mg | Office | 2022 | 16 | 98 | $98,980 | $71,040 | 71.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 261 | 550 | $53,900 | $35,197 | 65.3% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 216 | 241 | $33,258 | $19,251 | 57.9% |
About Dr. Daniel King, MD
Dr. Daniel King, MD is a Ophthalmology healthcare provider based in Red Bluff, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841226073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel King, MD has received a total of $662.24 in payments from pharmaceutical and medical device companies, with $159.04 received in 2023. These payments were reported across 13 transactions from 7 companies. The most common payment nature is "Food and Beverage" ($465.44).
As a Medicare-enrolled provider, King has provided services to 8,023 Medicare beneficiaries, totaling 12,203 services with total Medicare billing of $894,046. Data is available for 4 years (2020–2023), covering 87 distinct procedure/service records.
Ad
Practice Information
- Specialty Ophthalmology
- Other Specialties Ophthalmology
- Location Red Bluff, CA
- Active Since 06/22/2006
- Last Updated 01/16/2026
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1841226073
Products in Payments
- Centurion (Device) $223.80
- LUMIGAN (Drug) $94.13
- Hydrus (Device) $75.77
- VABYSMO (Drug) $46.80
- TEPEZZA (Drug) $24.40
- RESTASIS (Drug) $20.07
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.